Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Clinical neurodiagnostics

Factors influencing serum neurofilament light chain levels in normal aging.

Marisa Koini; Lukas Pirpamer; Edith Hofer; Arabella Buchmann; Daniela Pinter; Stefan Ropele; Christian Enzinger; Pascal Benkert; David Leppert; Jens Kuhle; Reinhold Schmidt; Michael Khalil

Originally published in Aging · 2021-12-18

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Objective Serum neurofilament light (sNfL) is a promising marker for neuro-axonal damage and it is now well known that its levels also increase with higher age. However, the effect of other determinants besides age is still poorly investigated. We therefore aimed to identify factors influencing the sNfL concentration by analysing a large set of demographical, life-style and clinical variables in a normal aging cohort. Methods sNfL was quantified by single molecule array (Simoa) assay in 327 neurologically inconspicuous individuals (median age 67.8±10.7 years, 192 female) who participated in the Austrian Stroke Prevention Family Study (ASPS-Fam). Random forest regression analysis was used to rank the association of included variables with sNfL in the entire cohort and in age-stratified subgroups. Linear regression then served to identify factors independently influencing sNfL concentration. Results Age (β=0.513, p Conclusions Age is the most important factor influencing sNfL concentrations, getting increasingly relevant in elderly people. BMI further influences sNfL levels, especially at younger age, whereas renal function gets increasingly relevant in the elderly.

DISCUSSION

In this study we comprehensively investigated factors influencing sNfL levels and determined their relative importance across different age groups in neurologically inconspicuous individuals.

Editorial reading guide

  • Which patient population and reference standard did the authors use?
  • Was the finding validated in a separate cohort, and how might patient selection affect it?